Evidence map›Paper›PMID 41680666›Full record

ArticleBMC infectious diseases2026

Association of serum Interleukin-6 with dysregulated lipid metabolism and nutritional status in patients with pulmonary tuberculosis: a case-control study.

Xiaohua Ma, Sifang Xiao, Aichun Tan, Aifeng Liu, Jian Xiao

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaohua MaDepartment of Laboratory, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China.
Sifang XiaoDepartment of Laboratory, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China.
Aichun TanDepartment of Laboratory, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China.
Aifeng LiuDepartment of Pathology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China. 2018050713@usc.edu.cn.
Jian XiaoDepartment of Laboratory, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, 410004, China. 7752135317@qq.com.

Funding

the Natural Science Foundation of Hunan Province NO.2025JJ80543the Scientific Research Project of Hunan Provincial Health Commission NO.20254080
6 · The paper itself

Abstract

backgroundThis study explores correlations between serum IL-6 levels, lipid metabolism, and nutritional status in pulmonary tuberculosis patients to advocate for integrating metabolic-nutritional assessments into routine TB care. It addresses a critical gap in current guidelines by linking IL-6-mediated inflammation to metabolic health, aligning with WHO’s holistic care principles.

methodsA case-control study was employed, which included 724 hospitalized patients diagnosed with pulmonary tuberculosis (the case group) from the tuberculosis department of a tertiary hospital between January 2023 and December 2023, matched with 724 healthy individuals who served as the control group. The indicators measured included lipid profile [Triglycerides (TG), Total Cholesterol (TC), High-Density Lipoprotein Cholesterol (HDL-C) and Low-Density Lipoprotein Cholesterol (LDL-C)], nutritional indicators [Total Protein (TP), Albumin (ALB) and Globulin (GLB)], and inflammatory indicators (IL-6). Statistical analyses employed SPSS 18.0, utilizing the Mann-Whitney U test for intergroup comparisons and Spearman’s correlation for association analyses, and multiple linear regression to identify independent predictors of serum IL-6 levels.

resultsCompared to the control group, the case group had significantly lower levels of TG, TC, HDL-C, LDL-C, TP, and ALB (Z=-25.107~-3.619, all P = 0.000), while GLB levels were significantly elevated (Z=-7.113, P = 0.000). After adjusting for 5 confounders, Spearman’s partial rank correlation analysis showed that TP had a positive correlation with TC, HDL-C and LDL-C (r = 0.115 ~ 0.181, P = 0.000 ~ 0.002), ALB had a positive correlation with TC and HDL-C (r = 0.271 ~ 0.466; all P = 0.000), while GLB had a negative correlation with HDL-C and LDL-C (r = -0.096~-0.266, P = 0.000 ~ 0.010). IL-6 was negatively correlated with TC, TG, HDL-C and LDL-C (r = -0.971~-0.220, all P = 0.000), and negatively correlated with TP and ALB (r = -0.253~-0.163, all P = 0.000). Multiple linear regression analysis, after controlling for confounders and addressing multicollinearity, further identified lower levels of LDL-C, HDL-C, triglycerides (TG), and globulin (GLB) as significant independent predictors of higher serum IL-6 concentrations (all P < 0.05). The final model explained a substantial proportion of the variance in IL-6 levels (Adjusted R² = 0.913).

conclusionThis study reveals that patients with pulmonary tuberculosis exhibit a metabolic-nutritional phenotype characterized by “hypolipidemia, hypoalbuminemia, and hyperglobulinemia”. Beyond correlation, multiple linear regression identified specific lipid fractions (LDL-C, HDL-C, TG) and globulin as independent predictors of IL-6 levels, indicating that IL-6 levels are significantly associated with these abnormalities and may reflect a shared underlying dysregulatory pathway. This research reinforces the management concept of viewing tuberculosis as a systemic metabolic disease and highly recommends that clinicians incorporate assessments of specific lipid profiles and protein fractions as a routine component of comprehensive tuberculosis management, with the goal of breaking the vicious cycle of “tuberculosis, malnutrition, and decreased immunity.” This approach could ultimately lead to better treatment outcomes for tuberculosis worldwide. CLINICAL TRIAL NUMBER : Not applicable.

Indexed as

Interleukin-6Lipid MetabolismNutritional StatusTuberculosis, PulmonaryAdultCase-Control StudiesCholesterol, HDLFemaleHumansLipidsMaleMiddle AgedTriglyceridesCholesterol, HDLIL6 protein, humanInterleukin-6LipidsTriglyceridesInflammatory cytokinesInterleukin-6 (IL-6)Lipid metabolismNutritional statusPulmonary tuberculosis

Identifiers

PMID41680666
PMCPMC13005510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.